Polyrizon Ltd. (PLRZ)
NASDAQ
$10.55+$0.0401 (+0.38%) on the dayAs of the close; data may be delayed.
PLRZ price, last 12 months
Key stats
- Previous close
- $10.51
- Open
- $10.50
- Day range
- $10.50 – $10.55
- 52-week range
- $2.88 – $18.20
- Volume
- 306
- Avg volume (20 days)
- 76.9K
- Market cap
- $25.9M
Performance
1W−4.0%
1M−9.5%
3M−8.1%
6M−23.3%
YTD+24.3%
1Y+64.3%
vs S&P 500, 1Y+47.6 pts
Technicals and fundamentals
About Polyrizon Ltd.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
- Listed on
- NASDAQ
- Market cap
- $25.9M